A new concept: treating corneal amblyopia with corneal wavefront guided LASIK

Article

Cases of amblyopia should undergo corneal wavefront analysis and would benefit from corneal wavefront-linked LASIK.

Cases of amblyopia should undergo corneal wavefront analysis and would benefit from corneal wavefront-linked LASIK, according to Cyres and Keiki Mehta from the Mehta International Eye Institute and Supervision Laser Center, Mumbai, India.

Over a period of one year, 60 cases of unilateral anisometropic amblyopia (age range seven to 25 years) were tested on the keratron scout topo-corneal wavefront analyser. The uncorrected and best corrected visual acuity (UCVA, BCVA) and total RMS were recorded.

LASIK was performed using a 200 Hz flying spot laser with a pupil-based tracker using a proprietary corneal wavefront-linking software (ORK-CAM; Schwind). Flaps were created using the Cariazzo-Pendular microkeratome with a 110 micron head.

Of the 60 eyes, nine improved by one line of BCVA, 47 improved by two lines and two eyes each improved by three and four lines. RMS corneal aberration decreased from between 40% to 56% and those subjects who recorded a greater reduction in RMS were also the subjects who gained more lines of BCVA.

In view of their results, the researchers concluded that all cases of amblyopia will benefit from corneal wavefront linked LASIK.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.